AM-111 Prevents Hearing Loss From Semicircular Canal Injury in Otitis Media

作者：Grindal Tyler C; Sampson Edith M; Antonelli Patrick J^*

来源：Laryngoscope, 2010, 120(1): 178-182.

DOI：10.1002/lary.20759

• Otitis media
• hearing loss
• mastoidectomy
• semicircular canal
• AM-111

Objectives/Hypothesis: Iatrogenic semicircular canal (SC) transection during mastoidectomy for chronic otitis media often leads to profound hearing loss. AM-111, an apoptosis inhibitor, has been shown to mitigate hearing loss resulting from a variety of inner ear injuries. The goal of this study was to determine if round window application of AM-111 following SC transection in the presence of Pseudomonas aeruginosa otitis media (PA-OM) may reduce the associated hearing loss.
Study Design: Prospective, randomized, controlled study in an animal model.
Methods: PA-OM was induced bilaterally in 34 guinea pigs. After 3 days, both bullae were opened and the lateral SC of one ear was transected. AM-111 or vehicle was applied topically to the round window of the ear that had undergone SC transection. Hearing was assessed with auditory brainstem responses.
Results: The mean change in hearing thresholds was significantly less in transected ears treated with AM-111 than those receiving vehicle alone when testing with clicks (22.1 dB vs. 35.0 dB; P = .019) and at 4kHz (11.3 dB vs. 40.0 dB; P = .021). A similar trend was shown with 16 kHz tone pips (27.7 dB vs. 41.1 dB; P = .119).
Conclusions: AM-111 prevents hearing loss from SC transection in the guinea pig model of PA-OM.

• 出版日期2010-1